Literature DB >> 1279431

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis.

D Shweiki1, A Itin, D Soffer, E Keshet.   

Abstract

Inefficient vascular supply and the resultant reduction in tissue oxygen tension often lead to neovascularization in order to satisfy the needs of the tissue. Examples include the compensatory development of collateral blood vessels in ischaemic tissues that are otherwise quiescent for angiogenesis and angiogenesis associated with the healing of hypoxic wounds. But the presumptive hypoxia-induced angiogenic factors that mediate this feedback response have not been identified. Here we show that vascular endothelial growth factor (VEGF; also known as vascular permeability factor) probably functions as a hypoxia-inducible angiogenic factor. VEGF messenger RNA levels are dramatically increased within a few hours of exposing different cell cultures to hypoxia and return to background when normal oxygen supply is resumed. In situ analysis of tumour specimens undergoing neovascularization show that the production of VEGF is specifically induced in a subset of glioblastoma cells distinguished by their immediate proximity to necrotic foci (presumably hypoxic regions) and the clustering of capillaries alongside VEGF-producing cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279431     DOI: 10.1038/359843a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1013 in total

Review 1.  Influence of host microvascular environment on tumour vascular endothelium.

Authors:  M Kubitza; L Hickey; W G Roberts
Journal:  Int J Exp Pathol       Date:  1999-02       Impact factor: 1.925

Review 2.  Glucose, VEGF-A, and diabetic complications.

Authors:  L E Benjamin
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 3.  Cellular responses to hypoxia in the pulmonary circulation.

Authors:  S O Brij; A J Peacock
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

Review 4.  Science, medicine, and the future. Antivascular therapy: a new approach to cancer treatment.

Authors:  A J Hayes; L Y Li; M E Lippman
Journal:  BMJ       Date:  1999-03-27

5.  Plexiform lesion in severe pulmonary hypertension: association with glomeruloid lesion.

Authors:  R M Tuder; N F Voelkel
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 6.  Antagonising angiogenesis in rheumatoid arthritis.

Authors:  P E Brenchley
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

7.  Can VEGF reverse diabetic neuropathy in human subjects?

Authors:  A Veves; G L King
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 8.  Angiogenesis in inflammatory joint disease: a target for therapeutic intervention.

Authors:  P E Brenchley
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

9.  Lake Tahoe invitation meeting 2002.

Authors: 
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

10.  Asperosaponin VI promotes angiogenesis and accelerates wound healing in rats via up-regulating HIF-1α/VEGF signaling.

Authors:  Cheng-Gui Wang; Yi-Ting Lou; Min-Ji Tong; Li-Lian Zhang; Zeng-Jie Zhang; Yong-Zeng Feng; Shi Li; Hua-Zi Xu; Cong Mao
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.